212 related articles for article (PubMed ID: 24476626)
41. G-Protein-Coupled Receptor 5 (LGR5) Overexpression Activates β-Catenin Signaling in Breast Cancer Cells via Protein Kinase A.
Chen Z; Xue C
Med Sci Monit Basic Res; 2019 Jan; 25():15-25. PubMed ID: 30662060
[TBL] [Abstract][Full Text] [Related]
42. Tissue-targeted R-spondin mimetics for liver regeneration.
Zhang Z; Broderick C; Nishimoto M; Yamaguchi T; Lee SJ; Zhang H; Chen H; Patel M; Ye J; Ponce A; Brady J; Baribault H; Li Y; Yeh WC
Sci Rep; 2020 Aug; 10(1):13951. PubMed ID: 32811902
[TBL] [Abstract][Full Text] [Related]
43. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
[TBL] [Abstract][Full Text] [Related]
44. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum.
Takahashi H; Ishii H; Nishida N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2011 Apr; 18(4):1166-74. PubMed ID: 21125339
[TBL] [Abstract][Full Text] [Related]
45. LGR5 and BMI1 Increase Pig Intestinal Epithelial Cell Proliferation by Stimulating WNT/β-Catenin Signaling.
Li XG; Wang Z; Chen RQ; Fu HL; Gao CQ; Yan HC; Xing GX; Wang XQ
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29601474
[TBL] [Abstract][Full Text] [Related]
46. Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma.
Lv Z; Yu JJ; Zhang WJ; Xiong L; Wang F; Li LF; Zhou XL; Gao XY; Ding XF; Han L; Cai YF; Ma W; Wang LX
Oncotarget; 2017 Apr; 8(16):26492-26504. PubMed ID: 28404917
[TBL] [Abstract][Full Text] [Related]
47. Targeting LGR5 in Colorectal Cancer: therapeutic gold or too plastic?
Morgan RG; Mortensson E; Williams AC
Br J Cancer; 2018 May; 118(11):1410-1418. PubMed ID: 29844449
[TBL] [Abstract][Full Text] [Related]
48. Induction of LGR5 by H2O2 treatment is associated with cell proliferation via the JNK signaling pathway in colon cancer cells.
Kim SH; Kim KH; Yoo BC; Ku JL
Int J Oncol; 2012 Nov; 41(5):1744-50. PubMed ID: 22923033
[TBL] [Abstract][Full Text] [Related]
49. VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6.
Dong Y; Zhang Y; Kang W; Wang G; Chen H; Higashimori A; Nakatsu G; Go M; Tong JH; Zheng S; To KF; Sung JJ; Yang X; Ng SS; Yu J
Theranostics; 2019; 9(22):6517-6531. PubMed ID: 31588233
[TBL] [Abstract][Full Text] [Related]
50. RSPO2 enriches LGR5(+) spheroid colon cancer stem cells and promotes its metastasis by epithelial-mesenchymal transition.
Zhang S; Han X; Wei B; Fang J; Wei H
Am J Transl Res; 2016; 8(2):354-64. PubMed ID: 27158331
[TBL] [Abstract][Full Text] [Related]
51. Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RW
Lee H; Sun R; Niehrs C
J Biol Chem; 2022 Feb; 298(2):101586. PubMed ID: 35032551
[TBL] [Abstract][Full Text] [Related]
52. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
[TBL] [Abstract][Full Text] [Related]
53. R-spondin2 signaling is required for oocyte-driven intercellular communication and follicular growth.
De Cian MC; Gregoire EP; Le Rolle M; Lachambre S; Mondin M; Bell S; Guigon CJ; Chassot AA; Chaboissier MC
Cell Death Differ; 2020 Oct; 27(10):2856-2871. PubMed ID: 32341451
[TBL] [Abstract][Full Text] [Related]
54. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.
Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503
[TBL] [Abstract][Full Text] [Related]
55. C‑mannosylation of R‑spondin2 activates Wnt/β‑catenin signaling and migration activity in human tumor cells.
Mizuta H; Kuga K; Suzuki T; Niwa Y; Dohmae N; Simizu S
Int J Oncol; 2019 Jun; 54(6):2127-2138. PubMed ID: 30942431
[TBL] [Abstract][Full Text] [Related]
56. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
[TBL] [Abstract][Full Text] [Related]
57. R-Spondin1/LGR5 Activates TGFβ Signaling and Suppresses Colon Cancer Metastasis.
Zhou X; Geng L; Wang D; Yi H; Talmon G; Wang J
Cancer Res; 2017 Dec; 77(23):6589-6602. PubMed ID: 28939678
[TBL] [Abstract][Full Text] [Related]
58. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
59. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
[TBL] [Abstract][Full Text] [Related]
60. The Matricellular Protein R-Spondin 2 Promotes Midbrain Dopaminergic Neurogenesis and Differentiation.
Gyllborg D; Ahmed M; Toledo EM; Theofilopoulos S; Yang S; Ffrench-Constant C; Arenas E
Stem Cell Reports; 2018 Sep; 11(3):651-664. PubMed ID: 30146491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
